Multiple Assemblies exist for SMTL entry 5sf1
Crystal Structure of human phosphodiesterase 10 in complex with 2-(difluoromethyl)-3-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazine; X-RAY DIFFRACTION 2.11 Å

	SMTL ID 5sf1.1 Ligands (4S)-2-(difluoromethyl)-3-methyl-6-[(1-methyl-4-phenyl-1H-imidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazine; ZINC ION; MAGNESIUM ION Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5sf1.2 Ligands (4S)-2-(difluoromethyl)-3-methyl-6-[(1-methyl-4-phenyl-1H-imidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazine; ZINC ION; MAGNESIUM ION Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5sf1.3 Ligands (4S)-2-(difluoromethyl)-3-methyl-6-[(1-methyl-4-phenyl-1H-imidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazine; ZINC ION; MAGNESIUM ION Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5sf1.4 Ligands (4S)-2-(difluoromethyl)-3-methyl-6-[(1-methyl-4-phenyl-1H-imidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazine; ZINC ION; MAGNESIUM ION Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer